Back in November, as Allergan was reeling from the news that it could face earlier-than-expected copies of its blockbuster eye drug Restasis, CEO Brent Saunders promised investors that cost cuts were ...

Allergan plc AGN, in a regulatory filing, announced that it is laying off over 1,000 employees as part of a cost-saving and restructuring program to protect it from potential revenue declines.

Amid investor pressure to split up its CEO and chairman roles, embattled Allergan is giving in—but only a bit. Allergan will support an investor resolution to split up the jobs, the company said on ...

Stung by a court decision late last year that invalidated its patents for its second best-selling drug, Allergan said it will eliminate 1400 jobs—1000 now-filled and 400 open positions—in a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Allergan Inc. said it will cut about 1,500 jobs over the remainder of this year as part of a restructuring plan to save about $475 million next year. The Business Journal last week reported that the ...